Ophthalmology Futures Retina & European Virtual Forums
Ophthalmology Futures Forums 2020
Ophthalmology Futures Retina & European Virtual Forums
Ophthalmology Futures Forums 2020
Vision Futures Ltd.
Ophthalmology Futures European Forum Secretariat
c/o Louise Richards (Managing Director), WBR Ltd
Vale House
Clarence Road
GB - TN1 1HE Tunbridge Wells
Fax: +44 (0)1892 512 180
-
Basisinformation
Datum30.09.2020, 13:50 - 01.10.2020, 22:15SpracheEnglischGebühren abgebührenfreiVeranstalterOphthalmology Futures Forum
Vision Futures Ltd.OrganisatorOphthalmology Futures European Forum Secretariat
c/o Louise Richards (Managing Director), WBR Ltd
Vale HouseClarence Road
GB - TN1 1HE Tunbridge Wells
Fax: +44 (0)1892 512 180 -
Programm
PLEASE NOTE: Times listed below are local Amsterdam times.
Please allow for the time difference in your location, for example:
-1 hour London, – 6 hours Eastern, – 9 hours PacificRetina Forum Provisional Programme, 30 September 2020
12:30 - 12:40 Welcome from the Co-chairs
14:00 - 14:30 Panel 1: Can AI Help Us Beyond Retinal Imaging?
14:30 - 15:00 Panel 2: Anti-VEGF Drugs for Retinal Disease: Is There Room for More?
15:00 - 15:20 A one to one with Marie-France Tschudin, President of Novartis Pharmaceuticals
15:20 - 16:10 Company Presentations 1
16:10 - 16:40 Panel 3: Gene and Cell-based Therapy for Retinal Disease: Opportunities and Challenges
16:40 - 16:50 Investment Overview
16:50 - 17:20 Panel 4: The Dream Versus the Reality: Making Investments in Retina, an Investor Perspective
17:20 - 18:10 Company Presentations 2
18:10 - 18:40 Panel 5: Surgical Instrumentation and Microscopy: A Real Business or a Revenue Rounding Error
18:40 - 19:10 Panel 6: Novel Drug Delivery Approaches for Posterior Segment Disease
19:10 - 19:30 A fireside chat with Dr Wiley Chambers, USFDA
19:30 - 20:30 Company Presentations 3
20:30 - 21:00 Panel 7: The Impact of COVID-19 on Retina Discovery, Development and Business
21:00 - 21:10Summary: Adnan Tufail
21:10 - 21:15 Concluding Remarks from the Co-chairs
European Forum Provisional Programme, 01 October 2020 12:30 - 12:40 Welcome from the Co-chairs
Keith Barton
Kuldev Singh12:40 - 12:50 Market Overview
Michael Giaquinto
12:50 - 13:20 Panel 1: The Global Dry Eye Opportunity: Will it Ever be Realised?
13:20 - 14:20 Company Presentations 1
14:20 - 14:50 Panel 2: Big idea and No Money: Who Do I Call in a Big Company?
14:50 - 15:10 Leadership Perspective
15:10 - 15:40 Panel 3: Drug Delivery for Eye Diseases: Simply Cool Technology or also a Commercial Success?
15:40 - 16:10 Panel 4: Cataract and Other Elective Surgery in the Era of COVID-19
16:10 - 17:10 Company Presentations 2
17:10 - 17:40 Panel 5: Refractive Outcomes after Cataract Surgery: IOL Adjustment Vs Enhancement
17:40 - 18:20 Panel 6: Premium IOL Patient-reported Outcomes and Regulatory Processes
Introductory talk and Discussion Panel
Chair: Dr Malvina Eydelman
18:20 - 19:20 Company Presentations 3
19:20 - 19:50 Panel 7: Will Endothelial Damage Restrict Glaucoma Device Progression?
19:50 - 20:20 Panel 8: Investment Panel
20:20 - 21:10 Company Presentations 4
21:10 - 21:40 Panel 9: Investment Panel
21:40 - 22:10 A View from the Top: The Long-term Impact of COVID-19 on the Business of Ophthalmology
Chair: James Mazzo
22:10 - 22:15 Summary and Concluding Remarks from Co-chairs
Keith Barton
Kuldev Singh -
Gebühren
Fachärzte/-innenGebühren abgebührenfreiÄrzte/-innen in WeiterbildungGebühren abgebührenfreiSonstigeGebühren abgebührenfrei(A saving of €800)
-
Buchung / Anmeldung
Registration required. Please contact the organizer for further information.
-
Zertifizierung
Keine Zertifizierung beantragt
-
Sponsoren
Carl Zeiss Ltd. (UK)
Alcon UK
Allergan UK
Sight Sciences
Novartis (US)
REGENXBIO Inc.
Aerie Pharmaceuticals Inc.
GenSight Biologics Inc.
Radiance Therapeutics Ltd
Avellino Labs USA, Inc.
LensGen Inc.
Oculis Switzerland
Beyeonics Surgical Ltd.
Centricity Vision